A comparison of nebulized budesonide and intramuscular dexamethasone for moderately and severe croup in children: A randomized clinical trial study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241229064209N1

Enrollment

Registered

2025-10-30

Start date

2025-01-03

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CROUP.

Interventions

Intervention 1: Intervention group: Inhaled budesonide recipients.35 people receive 2 mg of inhaled budesonide in addition to oxygen therapy and at the same time as inhaled epinephrine. Intervention 2

Eligibility

Sex/Gender

All

Age

6 Months to 18 Years

Inclusion criteria

Inclusion criteria: child Moderate to severe croup No comorbid respiratory disease No history of receiving corticosteroids in the last week

Exclusion criteria

Exclusion criteria: Mild or very severe croup comorbid respiratory disease receiving corticosteroids in the last week

Design outcomes

Primary

Measure	Time frame
Improving Krupp score according to Westley's table. Timepoint: Before.1 hour, 5 hours and 72 hours later. Method of measurement: WESTLEY TABLE.;Reducing the need for permanent hospitalization. Timepoint: Before.1 hour, 5 hours and 72 hours later. Method of measurement: WESTLEY TABLE.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasrin Eisapour

Yasouj University of Medical Sciences

Nasrin.isapour72@gmail.com+98 74 3333 2005

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026